# IL2 Imaging in Metastatic Melanoma

> **NCT02922283** · NA · TERMINATED · sponsor: **University Medical Center Groningen** · enrollment: 19 (actual)

## Conditions studied

- Melanoma

## Interventions

- **DEVICE:** IL2-PET scan
- **PROCEDURE:** Tumor biopsy
- **DEVICE:** CT scan
- **PROCEDURE:** Biopsy of non-target tissue

## Key facts

- **NCT ID:** NCT02922283
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-10-20
- **Primary completion:** 2020-02-14
- **Final completion:** 2020-02-14
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** After an interim analysis of the data, it became clear that the imaging results did not correlate to the primary outcome measures in this subset of patients.
- **Last updated:** 2024-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02922283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02922283, "IL2 Imaging in Metastatic Melanoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02922283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*